Paper41565660
An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression.
Zhang Y and 13 others. Nat Commun, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression. Papers, record 41565660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41565660
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ErbB Receptors | Major topic |
| Lung Neoplasms | Major topic |
| Mutation | Major topic |
| Glioma | Major topic |
| Humans | |
| Animals | |
| Afatinib | |
| Cell Line, Tumor | |
| Phosphorylation | |
| Mice | |
| Disease Progression | |
| Cell Proliferation | |
| Protein Kinase Inhibitors | |
| Mice, Nude | |
| Female |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 32470821 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 974077 | Nature of the Thermal pretransition of synthetic phospholipids: dimyristolyl- and dipalmitoyllecithin. | Biochemistry | 1976 | https://conductscience.org/library/papers/974077 | PubMed |
| 2 | 34787778 | Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial. | J Neurooncol | 2021 | https://conductscience.org/library/papers/34787778 | PubMed |
| 3 | 29990498 | Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29990498 | PubMed |
| 4 | 30854234 | Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer. | Signal Transduct Target Ther | 2019 | https://conductscience.org/library/papers/30854234 | PubMed |
| 5 | 15284455 | Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. | Science | 2004 | https://conductscience.org/library/papers/15284455 | PubMed |
| 6 | 26636222 | Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms. | J Chem Theory Comput | 2007 | https://conductscience.org/library/papers/26636222 | PubMed |
| 7 | 8530489 | Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor. | J Biol Chem | 1995 | https://conductscience.org/library/papers/8530489 | PubMed |
| 8 | 39470721 | Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39470721 | PubMed |
| 9 | 29462253 | Overview of current systemic management of EGFR-mutant NSCLC. | Ann Oncol | 2018 | https://conductscience.org/library/papers/29462253 | PubMed |
| 10 | 37805108 | Improving the efficacy of anti-EGFR drugs in GBM: Where we are going? | Biochim Biophys Acta Rev Cancer | 2023 | https://conductscience.org/library/papers/37805108 | PubMed |
| 11 | 20837704 | Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. | Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20837704 | PubMed |
| 12 | 22588883 | Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. | Cancer Discov | 2012 | https://conductscience.org/library/papers/22588883 | PubMed |
| 13 | 30075070 | Anomalous Effects of Velocity Rescaling Algorithms: The Flying Ice Cube Effect Revisited. | J Chem Theory Comput | 2018 | https://conductscience.org/library/papers/30075070 | PubMed |
| 14 | 25079552 | Comprehensive molecular profiling of lung adenocarcinoma. | Nature | 2014 | https://conductscience.org/library/papers/25079552 | PubMed |
| 15 | 24202392 | The quest to overcome resistance to EGFR-targeted therapies in cancer. | Nat Med | 2013 | https://conductscience.org/library/papers/24202392 | PubMed |
| 16 | 35113553 | Lipid21: Complex Lipid Membrane Simulations with AMBER. | J Chem Theory Comput | 2022 | https://conductscience.org/library/papers/35113553 | PubMed |
| 17 | 24803855 | Lipid14: The Amber Lipid Force Field. | J Chem Theory Comput | 2014 | https://conductscience.org/library/papers/24803855 | PubMed |
| 18 | 38548752 | Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants. | Nat Commun | 2024 | https://conductscience.org/library/papers/38548752 | PubMed |
| 19 | 10677291 | The GxxxG motif: a framework for transmembrane helix-helix association. | J Mol Biol | 2000 | https://conductscience.org/library/papers/10677291 | PubMed |
| 20 | 21367692 | Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21367692 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41565660
GET https://conductscience.org/api/papers/v1/41565660/references?page=2